Skip to main content
Clinical Trials/NCT05750927
NCT05750927CompletedNot Applicable

Aortic Stenosis With COmplex PCI (ASCOP) Features Retrospective Registry on Contemporary Management and Outcomes

Niguarda Hospital1 site in 1 country100 target enrollmentStarted: December 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
POCE

Study Overview

Brief Summary

To describe the prevalence and clinical features of patients with severe aortic stenosis undergoing TAVI and concomitant clinically indicated, complex and/or high-risk PCI

Detailed Description

The aims of this study are:

  • to describe the prevalence and clinical features of patients with severe aortic stenosis undergoing TAVI and concomitant clinically indicated, complex and/or high-risk PCI
  • to depict the different possible strategies that are currently employed in this context and to retrospectively analyze outcomes
  • to investigate predictors of better outcomes

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

POCE

Time Frame: 1 year

all-cause deaths, strokes (any), myocardial infarction and major bleedings

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Aortic Stenosis With COmplex PCI (ASCOP)... | Clinical Trial